tailieunhanh - Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors

Pancreatic ductal adenocarcinoma is a particularly challenging malignancy characterized by poor responsiveness to conventional chemotherapy. Although this tumor frequently overexpresses or possesses constitutively activated variants of IGF-IR and EGFR/Her-2, clinical trials using inhibitors of these receptors have failed. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN